You just read:

Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with argenx for Cancer Immunotherapy Cusatuzumab

News provided by

Cilag GmbH International

Dec 03, 2018, 01:01 ET